The foregoing findings revealed that relative to WDR1-Ab, BRAT1-Ab is a superior predictor of GI cancers and the AS-associated biomarker BRAT1-Ab is a potential predictor of the onset of ESCC, GC, and CRC. This evidence concerns the gene BRAT1 and colorectal carcinoma.